Characterization of the p68/p58 heterodimer of human immunodeficiency virus type 2 reverse transcriptase

被引:18
|
作者
Fan, NS
Rank, KB
Poppe, SM
Tarpley, WG
Sharma, SK
机构
[1] UPJOHN CO,UPJOHN LABS,BIOCHEM,KALAMAZOO,MI 49001
[2] UPJOHN CO,UPJOHN LABS,CAN & INFECT DIS RES,KALAMAZOO,MI 49001
关键词
D O I
10.1021/bi9516440
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recently we demonstrated that the p58 subunit of p68/p58 HIV-2 reverse transcriptase (RT) heterodimer, produced by processing of p68/p68 homodimer with recombinant HIV-2 protease, terminates at Met(484) [Fan, N., et al. (1995) J. Biol. Chem. 270, 13573-13579]. Here we describe purification and characterization of the p68/p58 heterodimer of recombinant HIV-2 RT. It exhibited both RT and RNase H activities, obeyed Michaelis-Menten kinetics, and was competitively inhibited by the DNA chain terminator ddTTP (K-i[app] = 305 +/- 20 nM). The HIV-2 RT-associated RNase H exhibited a marked preference for RNA hydrolysis from a HIV-1 gag-based heteropolymeric RNA/DNA hybrid in the presence of either Mg2+ or Mn2+, compared to the [H-3]poly(rA). poly(dT) or [H-3]poly(rG). poly(dC) homopolymeric substrates. Relative to HIV-1 RT, the RNase H activity of HIV-2 RT was only 5% toward the [H-3]poly(rA) poly(dT) in the presence of Mg2+. The size distribution of products generated from [H-3]poly(rA). poly(dT) by HIV-2 RT-associated RNase H was markedly distinct from that of HIV-1 RT in the presence of Mg2+ Or Mn2+. The p68/p58 HIV-2 RT heterodimer, produced by specific cleavage using HIV-2 protease, should be useful for inhibition and biophysical studies aimed at discovering and designing drugs directed toward HIV-2.
引用
收藏
页码:1911 / 1917
页数:7
相关论文
共 50 条
  • [21] Construction and characterization of a temperature-sensitive human immunodeficiency virus type 1 reverse transcriptase mutant
    Huang, MJ
    Zensen, R
    Cho, M
    Martin, MA
    JOURNAL OF VIROLOGY, 1998, 72 (03) : 2047 - 2054
  • [22] Human immunodeficiency virus type 2 reverse transcriptase activity in model systems that mimic steps in reverse transcription
    Post, K
    Guo, JH
    Howard, KJ
    Powell, MD
    Miller, JT
    Hizi, A
    Le Grice, SFJ
    Levin, JG
    JOURNAL OF VIROLOGY, 2003, 77 (13) : 7623 - 7634
  • [23] STRAND DISPLACEMENT ACTIVITY OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE HETERODIMER AND ITS INDIVIDUAL SUBUNITS
    HOTTIGER, M
    PODUST, VN
    THIMMIG, RL
    MCHENRY, C
    HUBSCHER, U
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (02) : 986 - 991
  • [24] Dimerization of human immunodeficiency virus type 1 reverse transcriptase as an antiviral target
    Srivastava, S.
    Sluis-Cremer, N.
    Tachedjian, G.
    CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (15) : 1879 - 1894
  • [25] ATP-dependent removal of nucleoside reverse transcriptase inhibitors by human immunodeficiency virus type 1 reverse transcriptase
    Naeger, LK
    Margot, NA
    Miller, MD
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (07) : 2179 - 2184
  • [26] Genotypic and functional characterization of mutations in the reverse transcriptase domain of the P gene of the hepatitis B virus, in patients coinfected with the human immunodeficiency virus receiving antiretrovirals
    Felipe Castro-Tobon, Andres
    Liseth Perez-Cala, Tania
    Martinez, Alonso
    Bautista-Amorocho, Henry
    IATREIA, 2021, 34 : S5 - S6
  • [27] Foamy Virus Gag p71-p68 Cleavage Is Required for Template Switch of the Reverse Transcriptase
    Spannaus, Ralf
    Schneider, Anna
    Hartl, Maximilian J.
    Woehrl, Birgitta M.
    Bodem, Jochen
    JOURNAL OF VIROLOGY, 2013, 87 (13) : 7774 - 7776
  • [28] Incorporation of human immunodeficiency virus type 1 reverse transcriptase into virus-like particles
    Liao, Wei-Hao
    Huang, Kuo-Jung
    Chang, Yu-Fen
    Wang, Shiu-Mei
    Tseng, Ying-Tzu
    Chiang, Chien-Cheng
    Wang, Jaang-Jiun
    Wang, Chin-Tien
    JOURNAL OF VIROLOGY, 2007, 81 (10) : 5155 - 5165
  • [29] INHIBITION OF THE P66/P51 FORM OF HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE-TRANSCRIPTASE BY TRANSFER RNALYS
    BORDIER, B
    TARRAGOLITVAK, L
    SALLAFRANQUEANDREOLA, ML
    ROBERT, D
    THARAUD, D
    FOURNIER, M
    BARR, PJ
    LITVAK, S
    SARIHCOTTIN, L
    NUCLEIC ACIDS RESEARCH, 1990, 18 (03) : 429 - 436
  • [30] CHARACTERIZATION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE ENZYME PRODUCED IN YEAST
    BATHURST, IC
    MOEN, LK
    LUJAN, MA
    GIBSON, HL
    FEUCHT, PH
    PICHUANTES, S
    CRAIK, CS
    SANTI, DV
    BARR, PJ
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 171 (02) : 589 - 595